Novel androgen therapies including selective androgen receptor modulators

被引:6
|
作者
Kang, Jungwoo [1 ]
Chen, Runzhi [2 ]
Tharakan, Tharu [1 ]
Minhas, Suks [3 ]
机构
[1] London Northwest Univ Healthcare NHS Trust, Northwick Pk Hosp, Dept Urol, Harrow HA1 3UJ, England
[2] Imperial Coll London, Fac Med, Sir Alexander Fleming Bldg,Imperial Coll Rd, London SW7 2AZ, England
[3] Imperial Coll Healthcare NHS Trust, Charing Cross Hosp, Dept Urol, London W6 8RF, England
关键词
male hypogonadism; testosterone replacement therapy; novel androgen therapies; nasal testosterone; TESTOSTERONE REPLACEMENT THERAPY; CONTRACEPTIVE EFFICACY; INFLAMMATORY CYTOKINES; AROMATASE INHIBITION; CLOMIPHENE CITRATE; HYPOGONADAL MEN; DOUBLE-BLIND; ELDERLY-MEN; RISK-FACTOR; OLDER MEN;
D O I
10.1016/j.beem.2022.101686
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Male hypogonadism is associated with reduced quality of life and the development of co-morbidities including obesity, diabetes mellitus, and dyslipidaemia. The mainstay of treatment for male hypogonadism is testosterone replacement therapy (TRT). How-ever, TRT has recognised side effects including impaired sper-matogenesis and there are concerns regarding its use in men with concurrent cardiovascular disease. Thus, there has been an impetus to develop novel androgen therapies for treating male hypogonadism to mitigate the side effects of TRT. This review will discuss the benefits and adverse effects of TRT, and novel therapies including nasal testosterone, aromatase inhibitors, selective oes-trogen receptor modulators, and selective androgen receptor modulators.(c) 2022 Elsevier Ltd. All rights reserved.
引用
收藏
页数:17
相关论文
共 50 条
  • [31] SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMs) IN THE CONTEXT OF DOPING
    Miklos, Amalia
    Tero-Vescan, Amelia
    Vari, Camil-Eugen
    Osz, Bianca-Eugenia
    Filip, Cristina
    Rusz, Carmen-Maria
    Muntean, Daniela-Lucia
    FARMACIA, 2018, 66 (05) : 758 - 762
  • [32] Design and synthesis of an array of selective androgen receptor modulators
    Trump, RP
    Turnbull, P
    Blanc, JBE
    Wiethe, RW
    Stewart, EL
    Caivano, M
    Gray, D
    Hoekstra, WJ
    Willson, TM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2508 - U2508
  • [33] Enhanced evaluation of selective androgen receptor modulators in vivo
    Otto-Duessel, M.
    He, M.
    Adamson, T. W.
    Jones, J. O.
    ANDROLOGY, 2013, 1 (01) : 29 - 36
  • [34] Recent advances in the development of selective androgen receptor modulators
    Zhang, Xuqing
    Lanter, James C.
    Sui, Zhihua
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2009, 19 (09) : 1239 - 1258
  • [35] Recent developments in antiandrogens and selective androgen receptor modulators
    Haendler, Bernard
    Cleve, Arwed
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2012, 352 (1-2) : 79 - 91
  • [36] Investigation of stability of selective androgen receptor modulators in urine
    Ventura, Emiliano
    Gadaj, Anna
    Buckley, Tom
    Mooney, Mark H.
    FOOD ADDITIVES AND CONTAMINANTS PART A-CHEMISTRY ANALYSIS CONTROL EXPOSURE & RISK ASSESSMENT, 2020, 37 (08): : 1253 - 1263
  • [37] Discovery of Diarylhydantoins as New Selective Androgen Receptor Modulators
    Nique, Francois
    Hebbe, Severine
    Peixoto, Christophe
    Annoot, Denis
    Lefrancois, Jean-Michel
    Duval, Eric
    Michoux, Laurence
    Triballeau, Nicolas
    Lemoullec, Jean-Michel
    Mollat, Patrick
    Thauvin, Maxime
    Prange, Thierry
    Minet, Dominique
    Clement-Lacroix, Philippe
    Robin-Jagerschmidt, Catherine
    Fleury, Damien
    Guedin, Denis
    Deprez, Pierre
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (19) : 8225 - 8235
  • [38] RECENT PROGRESS WITH SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMs)
    Dalton, James T.
    Narayanan, Ramesh
    Kearbey, Jeffrey D.
    Coss, Christopher C.
    Bob, Casey E.
    Jones, Amanda
    Barnette, K. Gary
    Rodriguez, Domingo
    Hancock, Michael
    Morton, Ronald A.
    Steiner, Mitchell S.
    JOURNAL OF ANDROLOGY, 2009, 30 : 21 - 22
  • [39] Drug Insight: testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging
    Bhasin, S
    Calof, OM
    Storer, TW
    Lee, ML
    Mazer, NA
    Jasuja, R
    Montori, VM
    Gao, WQ
    Dalton, JT
    NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2006, 2 (03): : 146 - 159
  • [40] Drug Insight: testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging
    Shalender Bhasin
    Olga M Calof
    Thomas W Storer
    Martin L Lee
    Norman A Mazer
    Ravi Jasuja
    Victor M Montori
    Wenqing Gao
    James T Dalton
    Nature Clinical Practice Endocrinology & Metabolism, 2006, 2 : 146 - 159